Suppr超能文献

早发性、晚期结直肠腺瘤/息肉中错配修复缺陷的流行情况:基于伊朗遗传性结直肠癌登记处的横断面研究。

Prevalence of Mismatch Repair-Deficient Colorectal Adenoma/Polyp in Early-Onset, Advanced Cases: a Cross-Sectional Study Based on Iranian Hereditary Colorectal Cancer Registry.

机构信息

Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Department of Gastroenterology and Hepatology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

出版信息

J Gastrointest Cancer. 2021 Mar;52(1):263-268. doi: 10.1007/s12029-020-00395-y.

Abstract

BACKGROUND

Lynch syndrome (LS) increases the risk of many types of cancer, mainly colorectal cancer (CRC). The purpose of this study was to assess the prevalence of mismatch repair (MMR) deficiency in patients under the age of 50 with advanced adenomatous polyps, aiming at an early diagnosis of LS.

METHODS

This retrospective, cross-sectional study included eligible patients with advanced adenomas diagnosed ≤ 50 years of age registered between April 2014 and February 2017 at three pathology centers in Mashhad. Pathological records were reviewed, and colon tissue specimens were analyzed by immunohistochemistry (IHC) staining to identify proteins which serve as markers for LS as they are related to loss of MMR gene (MLH1, MSH2, MSH6, and PMS2) expression.

RESULTS

Of 862 consecutive patients, a total of 50 adenomas (54% males, 46% females of mean age 41.24 ± 6.5) met the eligibility criteria. Of the adenomas examined, 20 (40%) had a tubulovillous component, 34 (68%) had high-grade dysplasia, and 30 (60%) had were larger than 10 mm protrusions. None of the patients had loss of MMR protein expression.

CONCLUSION

No individual with MMR genetic disorder was identified by IHC screening of early-onset advanced colorectal adenomas. This strategy is therefore not an effective strategy for detecting MMR mutation carriers.

摘要

背景

林奇综合征(LS)会增加多种癌症的风险,主要是结直肠癌(CRC)。本研究的目的是评估 50 岁以下患有晚期腺瘤性息肉的患者错配修复(MMR)缺陷的患病率,旨在早期诊断 LS。

方法

本回顾性、横断面研究纳入了 2014 年 4 月至 2017 年 2 月在马什哈德的三个病理中心诊断为 ≤ 50 岁的符合条件的晚期腺瘤患者。对病理记录进行了回顾,并通过免疫组织化学(IHC)染色分析结肠组织标本,以鉴定 LS 的标志物蛋白,因为它们与 MMR 基因(MLH1、MSH2、MSH6 和 PMS2)表达缺失有关。

结果

在 862 例连续患者中,共有 50 个腺瘤(54%为男性,46%为女性,平均年龄为 41.24 ± 6.5 岁)符合入选标准。在检查的腺瘤中,20 个(40%)具有管状绒毛成分,34 个(68%)具有高级别异型增生,30 个(60%)大于 10mm 突出。没有患者出现 MMR 蛋白表达缺失。

结论

通过对早发性结直肠高级别腺瘤进行 IHC 筛查,未发现个体存在 MMR 遗传异常。因此,该策略不是检测 MMR 突变携带者的有效策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验